Piramal Pharma Solutions (PPS), a leading global Contract Development and Manufacturing Organization (CDMO) and part of Piramal Pharma Ltd. has unveiled an $80M investment plan to expand its Lexington, Kentucky facility. The site specializes in sterile compounding, liquid filling, and lyophilization for sterile inject…
Octagos Health, the leader in AI-powered remote cardiac monitoring, announced significant advancements in product integration, enhanced AI functionality, and strategic talent investments. Following its recent $43 million Series B funding, the company is expanding its data integration capabilities to include a broader …
Castle Biosciences, Inc a company improving health through innovative tests that guide patient care, announced that it will hold a groundbreaking ceremony to celebrate the recent construction start of its new corporate campus and office building. The ceremony will take place on Oct. 22, 2024, at 10:00 a.m. Central tim…
Ferring Pharmaceuticals announced the opening of a state-of-the-art global manufacturing hub in Finland for the drug substance of its intravesical non-replicating gene therapy Adstiladrin (nadofaragene firadenovec-vncg). This represents a significant milestone in Ferring’s capabilities and capacity to meet the current…
Orbis Medicines, a leader in oral macrocycle drug discovery, today announced a significant expansion of its operations and capabilities by establishing itself at Symbion’s new biotech hub in Fuglebakken, Copenhagen. Symbion is Denmark’s largest start-up ecosystem. The site will host further R&D personnel and execu…
Lonza, one of the world’s largest healthcare development and manufacturing organizations, announced it has completed its acquisition of the Genentech large-scale biologics manufacturing site in Vacaville, California (US) from Roche for USD 1.2 billion. The Vacaville facility significantly extends Lonza’s capacity for…
Eli Lilly and Company announced a $4.5 billion investment to create the Lilly Medicine Foundry, a new center for advanced manufacturing and drug development. This unique facility will give Lilly the ability to research new ways of producing medicines, while also scaling up manufacturing of medicines for clinical trial…
Aspen Neuroscience, Inc., a private biotechnology company developing personalized (autologous) cell therapies, announced the expansion of its San Diego footprint near its headquarters in Torrey Pines, with a new 22,000 square foot facility for GMP manufacturing of induced pluripotent stem cell (iPSC)-derived cell ther…
Sanyou Bio recently celebrated a prestigious move into its new 10,000-square-meter R&D building at Shanghai headquarters. This is not just a change in physical location, but a qualitative leap in the company infrastructure. It marks a solid step forward for Sanyou Bio to accelerate the development of innovative bi…
PCI Pharma Services,a leading global contract development and manufacturing organization (CDMO) focused on biopharma’s most complex therapies, is investing more than $365 million in infrastructure supporting the clinical and commercial-scale final assembly and packaging of drug-device combination products utilizing ad…
Page 31 of 58